AU2009314345B2 - Method of producing serum-free insulin-free Factor VII - Google Patents

Method of producing serum-free insulin-free Factor VII Download PDF

Info

Publication number
AU2009314345B2
AU2009314345B2 AU2009314345A AU2009314345A AU2009314345B2 AU 2009314345 B2 AU2009314345 B2 AU 2009314345B2 AU 2009314345 A AU2009314345 A AU 2009314345A AU 2009314345 A AU2009314345 A AU 2009314345A AU 2009314345 B2 AU2009314345 B2 AU 2009314345B2
Authority
AU
Australia
Prior art keywords
insulin
free
cells
serum
media
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2009314345A
Other languages
English (en)
Other versions
AU2009314345A1 (en
Inventor
Ruth Elmer
Manfred Reiter
Simone Von Fircks
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxalta GmbH
Baxalta Inc
Original Assignee
Baxalta GmbH
Baxalta Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42165541&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2009314345(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxalta GmbH, Baxalta Inc filed Critical Baxalta GmbH
Publication of AU2009314345A1 publication Critical patent/AU2009314345A1/en
Application granted granted Critical
Publication of AU2009314345B2 publication Critical patent/AU2009314345B2/en
Assigned to BAXALTA INCORPORATED, Baxalta GmbH reassignment BAXALTA INCORPORATED Request for Assignment Assignors: BAXTER HEALTHCARE S.A., BAXTER INTERNATIONAL INC.
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C12N2500/95—Protein-free medium and culture conditions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2009314345A 2008-11-12 2009-11-05 Method of producing serum-free insulin-free Factor VII Ceased AU2009314345B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11379208P 2008-11-12 2008-11-12
US61/113,792 2008-11-12
PCT/US2009/063338 WO2010056584A1 (en) 2008-11-12 2009-11-05 Method of producing serum-free insulin-free factor vii

Publications (2)

Publication Number Publication Date
AU2009314345A1 AU2009314345A1 (en) 2011-06-30
AU2009314345B2 true AU2009314345B2 (en) 2015-02-12

Family

ID=42165541

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2009314345A Ceased AU2009314345B2 (en) 2008-11-12 2009-11-05 Method of producing serum-free insulin-free Factor VII

Country Status (15)

Country Link
US (1) US20100120093A1 (https=)
EP (2) EP2356247B2 (https=)
JP (1) JP5719301B2 (https=)
AU (1) AU2009314345B2 (https=)
CA (1) CA2742107A1 (https=)
DK (1) DK2356247T4 (https=)
ES (1) ES2547881T5 (https=)
HK (1) HK1219113A1 (https=)
HR (1) HRP20151054T4 (https=)
HU (1) HUE026210T2 (https=)
IL (1) IL212355A (https=)
PL (1) PL2356247T5 (https=)
PT (1) PT2356247E (https=)
SI (1) SI2356247T2 (https=)
WO (1) WO2010056584A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013535981A (ja) * 2010-08-20 2013-09-19 ワイス・エルエルシー 成長因子不含適合細胞の細胞培養
US20120076779A1 (en) 2010-09-17 2012-03-29 Baxter Healthcare S.A. STABILIZATION OF IMMUNOGLOBULINS AND OTHER PROTEINS THROUGH AQUEOUS FORMULATIONS WITH SODIUM CHLORIDE AT WEAK ACIDIC TO NEUTRAL ph
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
AR095196A1 (es) 2013-03-15 2015-09-30 Regeneron Pharma Medio de cultivo celular libre de suero
KR20150026024A (ko) * 2013-08-30 2015-03-11 한미약품 주식회사 인간 혈액응고 7인자 유도체의 대량 생산 방법
US11286292B2 (en) 2014-02-07 2022-03-29 Cmc Biologics A/S Bioreactor arrangement and continuous process for producing and capturing a biopolymer
NZ724826A (en) * 2014-04-16 2022-07-29 Cmc Biologics As A high cell density fill and draw fermentation process
AU2015269365A1 (en) 2014-06-04 2016-12-15 Amgen Inc. Methods for harvesting mammalian cell cultures
US12297451B1 (en) 2019-10-25 2025-05-13 Regeneron Pharmaceuticals, Inc. Cell culture medium

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100061A (en) * 1997-06-20 2000-08-08 Immuno Aktiengesellschaft Recombinant cell clone having increased stability in serum- and protein-free medium and a method of recovering the stable cell clone and the production of recombinant proteins by using a stable cell clone
US20040185535A1 (en) * 2003-03-21 2004-09-23 Giles Wilson Industrial-scale serum-free production of recombinant FVII in mammalian cells

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456591A (en) 1981-06-25 1984-06-26 Baxter Travenol Laboratories, Inc. Therapeutic method for activating factor VII
GR860984B (en) 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
US5997864A (en) 1995-06-07 1999-12-07 Novo Nordisk A/S Modified factor VII
US5804420A (en) * 1997-04-18 1998-09-08 Bayer Corporation Preparation of recombinant Factor VIII in a protein free medium
AT409379B (de) † 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
DK1200561T3 (da) † 1999-08-05 2006-10-16 Baxter Ag Rekombinant stabil celleklon, dens fremstilling og anvendelse
US20030204338A1 (en) 2002-04-22 2003-10-30 Peter Martinek Method and measurement probe for the performance of measurements in water supply systems
BR0114373A (pt) * 2000-10-02 2004-02-17 Novo Nordisk As Célula hospedeira eucariótica, métodos para a produção de fvii e de fviia ou de suas variantes, de uma proteìna dependente de vitamina k e de uma célula hospedeira eucariótica produtora de fvii ou de seu análogo, vetor recombinante, fvii e fviia recombinante ou suas variantes, e, proteìna dependente de vitamina k recombinante
EP1434857B1 (en) * 2001-10-02 2007-08-01 Novo Nordisk Health Care AG Method for production of recombinant proteins in eukaryote cells
US20050214289A1 (en) * 2004-03-26 2005-09-29 Human Genome Sciences, Inc. Antibodies against Nogo receptor
US20060094104A1 (en) 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
EP1851305B1 (en) * 2005-02-11 2012-01-18 Novo Nordisk Health Care AG Production of a polypeptide in a serum-free cell culture liquid containing plant protein hydrolysate
CN101300342A (zh) † 2005-11-02 2008-11-05 惠氏公司 用于使哺乳动物细胞具备适应性的方法
ES2474573T3 (es) † 2006-01-04 2014-07-09 Baxter International Inc Medio de cultivo celular sin oligop�ptidos

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100061A (en) * 1997-06-20 2000-08-08 Immuno Aktiengesellschaft Recombinant cell clone having increased stability in serum- and protein-free medium and a method of recovering the stable cell clone and the production of recombinant proteins by using a stable cell clone
US20040185535A1 (en) * 2003-03-21 2004-09-23 Giles Wilson Industrial-scale serum-free production of recombinant FVII in mammalian cells

Also Published As

Publication number Publication date
PL2356247T5 (pl) 2019-10-31
SI2356247T1 (sl) 2015-11-30
HK1219113A1 (en) 2017-03-24
PT2356247E (pt) 2015-10-26
CA2742107A1 (en) 2010-05-20
EP2977461A1 (en) 2016-01-27
JP2012508562A (ja) 2012-04-12
IL212355A0 (en) 2011-06-30
US20100120093A1 (en) 2010-05-13
JP5719301B2 (ja) 2015-05-13
ES2547881T5 (es) 2019-10-16
EP2356247A4 (en) 2013-01-02
PL2356247T3 (pl) 2016-04-29
WO2010056584A1 (en) 2010-05-20
SI2356247T2 (sl) 2019-08-30
EP2356247A1 (en) 2011-08-17
IL212355A (en) 2016-04-21
HRP20151054T4 (hr) 2019-11-15
EP2356247B2 (en) 2019-05-15
EP2356247B1 (en) 2015-07-15
HRP20151054T1 (xx) 2015-11-20
HUE026210T2 (en) 2016-05-30
ES2547881T3 (es) 2015-10-09
AU2009314345A1 (en) 2011-06-30
DK2356247T3 (en) 2015-09-21
DK2356247T4 (da) 2019-06-03

Similar Documents

Publication Publication Date Title
AU2009314345B2 (en) Method of producing serum-free insulin-free Factor VII
EP1325147A2 (en) Industrial-scale serum-free production of recombinant factor vii in mammalian cells
US20090263866A1 (en) Industrial-scale Serum-free Production of Recombinant Factor VII in Mammalian Cells
Avgerinos et al. Spin filter perfusion system for high density cell culture: production of recombinant urinary type plasminogen activator in CHO cells
KR101798813B1 (ko) 세포 배양 방법
EP1434857B1 (en) Method for production of recombinant proteins in eukaryote cells
KR102568951B1 (ko) 포유류 세포의 배양 방법
JP2007508003A (ja) 真核生物細胞におけるポリペプチドの大規模生産方法及びそれに適した培養容器
Hu et al. Pilot production of u-PA with porous microcarrier cell culture
US20090075331A1 (en) Industrial-scale serum-free production of recombinant proteins in mammalian cells
AU2014274601B2 (en) Cell Culture Processes
JP2011004754A (ja) 組換え安定細胞クローン、その産生およびその使用

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: BAXALTA INCORPORATED; BAXALTA GMBH

Free format text: FORMER OWNER WAS: BAXTER HEALTHCARE S.A.; BAXTER INTERNATIONAL INC.

MK14 Patent ceased section 143(a) (annual fees not paid) or expired